tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

DVAX Stock Latest News

Dynavax doses first patient in Phase 1/2 clinical trial evaluating Z-1018
The FlyDynavax doses first patient in Phase 1/2 clinical trial evaluating Z-1018
25d ago
DVAX
Dynavax Technologies (NASDAQ:DVAX): A Promising Biopharma Option Despite Recent Challenges
PremiumMarket News
Dynavax Technologies (NASDAQ:DVAX): A Promising Biopharma Option Despite Recent Challenges
25d ago
DVAX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
RNA
AXSM
Dynavax CRL for four-dose Heplisav-B doesn’t change H.C. Wainwright estimates
PremiumThe Fly
Dynavax CRL for four-dose Heplisav-B doesn’t change H.C. Wainwright estimates
2M ago
DVAX
Dynavax provides regulatory update on sBLA for four-dose HEPLISAV-B regimen
PremiumThe Fly
Dynavax provides regulatory update on sBLA for four-dose HEPLISAV-B regimen
2M ago
DVAX
Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates
PremiumPress ReleasesDynavax Reports First Quarter 2024 Financial Results and Provides Business Updates
2M ago
DVAX
Dynavax sees 2024 product revenue $265M-$280M
PremiumThe Fly
Dynavax sees 2024 product revenue $265M-$280M
2M ago
DVAX
Dynavax reports Q1 EPS (7c), consensus (2c)
PremiumThe Fly
Dynavax reports Q1 EPS (7c), consensus (2c)
2M ago
DVAX
DVAX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
DVAX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
DVAX
Dynavax Appoints Interim CFO During MacDonald’s Leave
PremiumCompany Announcements
Dynavax Appoints Interim CFO During MacDonald’s Leave
4M ago
8K
DVAX
Dynavax (NASDAQ:DVAX): Potential Growth at a Rich Valuation
PremiumMarket News
Dynavax (NASDAQ:DVAX): Potential Growth at a Rich Valuation
4M ago
DVAX
Dynavax Secures New Sublease Agreement Amidst Zymergen’s Bankruptcy
PremiumCompany Announcements
Dynavax Secures New Sublease Agreement Amidst Zymergen’s Bankruptcy
4M ago
8K
DVAX
Dynavax price target raised to $29 from $28 at H.C. Wainwright
PremiumThe FlyDynavax price target raised to $29 from $28 at H.C. Wainwright
5M ago
DVAX
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance
PremiumPress Releases
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance
5M ago
DVAX
Dynavax sees 2024 Heplisav-B product revenue $265M-$280M
PremiumThe Fly
Dynavax sees 2024 Heplisav-B product revenue $265M-$280M
5M ago
DVAX
Dynavax reports Q4 EPS 0c, consensus (1c)
PremiumThe Fly
Dynavax reports Q4 EPS 0c, consensus (1c)
5M ago
DVAX
Qualcomm downgraded, Cigna upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Qualcomm downgraded, Cigna upgraded: Wall Street’s top analyst calls
6M ago
T
CI
Dynavax initiated with a Neutral at Goldman Sachs
PremiumThe Fly
Dynavax initiated with a Neutral at Goldman Sachs
6M ago
DVAX
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
PremiumPress Releases
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
7M ago
DVAX
Dynavax sees FY23 HEPLISAV-B vaccine net product revenue about $213M
PremiumThe FlyDynavax sees FY23 HEPLISAV-B vaccine net product revenue about $213M
7M ago
DVAX
Dynavax sees Q4 HEPLISAV-B vaccine net product revenue about $51M
PremiumThe Fly
Dynavax sees Q4 HEPLISAV-B vaccine net product revenue about $51M
7M ago
DVAX
Dynavax price target raised to $27 from $25 at JMP Securities
PremiumThe Fly
Dynavax price target raised to $27 from $25 at JMP Securities
9M ago
DVAX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >